Recently, the signal transducer and activator of transcription3 (STAT3) signaling pathway, which is constitutively activated in a variety of human neoplasms [10], such as leukemia, head and neck cancer, melanoma, breast cancer, prostate cancer, and glioma, has become a focal point of cancer research. This evidence concerns the gene STAT3 and central nervous system cancer.